TY - JOUR
T1 - Antenatal hypoxia and pulmonary vascular function and remodeling
AU - Papamatheakis, Demosthenes G.
AU - Blood, Arlin B.
AU - Kim, Joon H.
AU - Wilson, Sean M.
N1 - This review provides evidence that antenatal hypoxia, which represents a significant and worldwide problem, causes prenatal programming of the lung. A gene...
PY - 2013/9
Y1 - 2013/9
N2 - This review provides evidence that antenatal hypoxia, which represents a significant and worldwide problem, causes prenatal programming of the lung. A general overview of lung development is provided along with some background regarding transcriptional and signaling systems of the lung. The review illustrates that antenatal hypoxic stress can induce a continuum of responses depending on the species examined. Fetuses and newborns of certain species and specific human populations are well acclimated to antenatal hypoxia. However, antenatal hypoxia causes pulmonary vascular disease in fetuses and newborns of most mammalian species and humans. Disease can range from mild pulmonary hypertension, to severe vascular remodeling and dangerous elevations in pressure. The timing, length, and magnitude of the intrauterine hypoxic stress are important to disease development, however there is also a genetic-environmental relationship that is not yet completely understood. Determining the origins of pulmonary vascular remodeling and pulmonary hypertension and their associated effects is a challenging task, but is necessary in order to develop targeted therapies for pulmonary hypertension in the newborn due to antenatal hypoxia that can both treat the symptoms and curtail or reverse disease progression.
AB - This review provides evidence that antenatal hypoxia, which represents a significant and worldwide problem, causes prenatal programming of the lung. A general overview of lung development is provided along with some background regarding transcriptional and signaling systems of the lung. The review illustrates that antenatal hypoxic stress can induce a continuum of responses depending on the species examined. Fetuses and newborns of certain species and specific human populations are well acclimated to antenatal hypoxia. However, antenatal hypoxia causes pulmonary vascular disease in fetuses and newborns of most mammalian species and humans. Disease can range from mild pulmonary hypertension, to severe vascular remodeling and dangerous elevations in pressure. The timing, length, and magnitude of the intrauterine hypoxic stress are important to disease development, however there is also a genetic-environmental relationship that is not yet completely understood. Determining the origins of pulmonary vascular remodeling and pulmonary hypertension and their associated effects is a challenging task, but is necessary in order to develop targeted therapies for pulmonary hypertension in the newborn due to antenatal hypoxia that can both treat the symptoms and curtail or reverse disease progression.
KW - Fetal programming
KW - Hypoxia
KW - Newborns
KW - Pulmonary hypertension
KW - Sheep
KW - Animals
KW - Hypoxia/physiopathology
KW - Humans
KW - Lung/blood supply
KW - Hypertension, Pulmonary/physiopathology
KW - Disease Progression
KW - Infant, Newborn
UR - http://www.scopus.com/inward/record.url?scp=84888101619&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84888101619&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/885a3ff3-1134-3ac8-852c-8af8069362e8/
U2 - 10.2174/1570161111311050006
DO - 10.2174/1570161111311050006
M3 - Article
C2 - 24063380
SN - 1570-1611
VL - 11
SP - 616
EP - 640
JO - Current Vascular Pharmacology
JF - Current Vascular Pharmacology
IS - 5
ER -